Technical Analysis for ADMP - Adamis Pharmaceuticals Corporation

Grade Last Price % Change Price Change
D 1.145 2.23% 0.03
ADMP closed unchanged on Monday, March 1, 2021, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ADMP trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 2.68%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.68%
Narrow Range Bar Range Contraction 2.68%
NR7 Range Contraction 2.68%
Wide Bands Range Expansion 2.68%
Oversold Stochastic Weakness 2.68%
Doji - Bullish? Reversal 2.68%
Wide Bands Range Expansion 2.68%
Oversold Stochastic Weakness 2.68%
Stochastic Reached Oversold Weakness 3.60%
Older End-of-Day Signals for ADMP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 41 minutes ago
Up 3% 41 minutes ago
Up 2% about 2 hours ago
Up 1% about 2 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Adamis Pharmaceuticals Corporation Description

Adamis Pharmaceuticals Corporation, a biopharmaceutical company, engages in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of oncology, immunology and infectious diseases, and allergy and respiratory. The company focuses on the development of small molecule compounds, which comprise APC-100, APC-200, and APC-300 for the treatment of human prostate cancer; telomerase vaccine technologies; and other vaccine technologies for providing protection against various viral infectious agents. Its products under development also comprise TeloB-VAX, a novel cell-based vaccine product for prostate cancer; and Savvy(C31G), a contraceptive gel. The company's allergy and respiratory product pipeline includes Epinephrine Injection USP 1, a pre-filled single dose syringe product for use in the emergency treatment of extreme acute allergic reactions or anaphylactic shock; APC-1000, a steroid hydrofluoroalkane (HFA) metered dose inhaler product for asthma and chronic obstructive pulmonary disease; APC-2000, a generic HFA bronchodilator; and APC-3000, an HFA pressurized metered dose nasal steroid for the treatment of seasonal and perennial allergic rhinitis. It has a strategic manufacturing, supply, and product development agreement with Beximco Pharmaceuticals Ltd. The company is based in San Diego, California.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Immunology Infectious Diseases Pharmaceutical Products Prostate Cancer Respiratory Therapy Dosage Forms Asthma Allergy Pulmonary Disease Chronic Obstructive Pulmonary Disease Syringe Smoking Cessation C3 Inhaler Telomerase Bronchodilator Emergency Treatment Infectious Agents Metered Dose Inhaler Rhinitis

Is ADMP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.34
52 Week Low 0.27
Average Volume 22,046,186
200-Day Moving Average 0.80
50-Day Moving Average 1.03
20-Day Moving Average 1.32
10-Day Moving Average 1.30
Average True Range 0.18
ADX 34.05
+DI 28.54
-DI 24.38
Chandelier Exit (Long, 3 ATRs ) 1.21
Chandelier Exit (Short, 3 ATRs ) 1.56
Upper Bollinger Band 1.70
Lower Bollinger Band 0.94
Percent B (%b) 0.23
BandWidth 57.36
MACD Line 0.02
MACD Signal Line 0.09
MACD Histogram -0.0652
Fundamentals Value
Market Cap 104.9 Million
Num Shares 93.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -1.35
Price-to-Sales 1.64
Price-to-Book 1.49
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.21
Resistance 3 (R3) 1.22 1.19 1.20
Resistance 2 (R2) 1.19 1.17 1.19 1.19
Resistance 1 (R1) 1.16 1.16 1.15 1.15 1.18
Pivot Point 1.13 1.13 1.13 1.13 1.13
Support 1 (S1) 1.10 1.11 1.09 1.09 1.06
Support 2 (S2) 1.07 1.10 1.07 1.05
Support 3 (S3) 1.04 1.07 1.05
Support 4 (S4) 1.03